Always consult with your healthcare provider before making changes to your medication.
"PRAC concludes eye condition NAION is a very rare side effect of semaglutide medicines Ozempic, Rybelsus and Wegovy"
Licensed pharmacological options that have been thoroughly evaluated for safety and efficacy include: Orlistat : A lipase inhibitor that reduces fat absorption from the diet Liraglutide (Saxenda) and semaglutide (Wegovy) : GLP-1 receptor agonists similar to tirzepatide but with more extensive long-term safety data Naltrexone-bupropion (Mysimba) : A combination medication affecting appetite and reward pathways Each of these has specific indications, contraindications, and monitoring requirements that should be discussed with a healthcare professional
Additive GI burden: Nausea, vomiting, and diarrhea are dose-dependent, GLP-1-mediated effects
This raises a provocative question: Are we on the brink of a paradigm shift in sleep apnea treatment
For a 220-pound (100 kg) starting weight, thats roughly 33 pounds